Liquidia (LQDA) Competitors $14.87 -0.62 (-4.00%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$14.87 0.00 (0.00%) As of 03/3/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LQDA vs. NARI, IRTC, NVST, PRCT, LIVN, TMDX, ENOV, WRBY, NVCR, and LMATShould you be buying Liquidia stock or one of its competitors? The main competitors of Liquidia include Inari Medical (NARI), iRhythm Technologies (IRTC), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), TransMedics Group (TMDX), Enovis (ENOV), Warby Parker (WRBY), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Liquidia vs. Inari Medical iRhythm Technologies Envista PROCEPT BioRobotics LivaNova TransMedics Group Enovis Warby Parker NovoCure LeMaitre Vascular Liquidia (NASDAQ:LQDA) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation. Do institutionals and insiders believe in LQDA or NARI? 64.5% of Liquidia shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 30.1% of Liquidia shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to LQDA or NARI? In the previous week, Inari Medical had 3 more articles in the media than Liquidia. MarketBeat recorded 5 mentions for Inari Medical and 2 mentions for Liquidia. Liquidia's average media sentiment score of 0.94 beat Inari Medical's score of 0.77 indicating that Liquidia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inari Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, LQDA or NARI? Liquidia has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Does the MarketBeat Community prefer LQDA or NARI? Liquidia received 136 more outperform votes than Inari Medical when rated by MarketBeat users. Likewise, 68.24% of users gave Liquidia an outperform vote while only 57.89% of users gave Inari Medical an outperform vote. CompanyUnderperformOutperformLiquidiaOutperform Votes20268.24% Underperform Votes9431.76% Inari MedicalOutperform Votes6657.89% Underperform Votes4842.11% Which has stronger valuation & earnings, LQDA or NARI? Inari Medical has higher revenue and earnings than Liquidia. Inari Medical is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia$15.61M80.62-$78.50M-$1.63-9.12Inari Medical$493.63M9.48-$1.64M-$1.35-59.24 Do analysts recommend LQDA or NARI? Liquidia currently has a consensus price target of $25.38, indicating a potential upside of 70.65%. Inari Medical has a consensus price target of $68.00, indicating a potential downside of 14.97%. Given Liquidia's stronger consensus rating and higher probable upside, equities analysts clearly believe Liquidia is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 Is LQDA or NARI more profitable? Inari Medical has a net margin of -13.68% compared to Liquidia's net margin of -765.38%. Inari Medical's return on equity of -10.09% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Liquidia-765.38% -163.21% -67.14% Inari Medical -13.68%-10.09%-6.60% SummaryLiquidia beats Inari Medical on 10 of the 19 factors compared between the two stocks. Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidiaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.26B$7.20B$5.81B$8.39BDividend YieldN/A2.79%4.75%3.98%P/E Ratio-9.126.1524.9519.22Price / Sales80.62187.68375.54110.22Price / CashN/A65.6738.0534.58Price / Book20.376.447.334.28Net Income-$78.50M$139.03M$3.18B$247.04M7 Day Performance-6.42%-5.52%-4.42%-4.36%1 Month Performance3.77%-8.56%-6.07%-5.60%1 Year Performance2.41%-14.59%11.42%3.38% Liquidia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia2.9688 of 5 stars$14.87-4.0%$25.38+70.6%+2.4%$1.26B$15.61M-9.1250NARIInari Medical1.6732 of 5 stars$79.97+0.1%$68.00-15.0%N/A$4.68B$493.63M-59.241,300High Trading VolumeIRTCiRhythm Technologies0.7408 of 5 stars$118.88-0.5%$119.73+0.7%-9.5%$3.73B$560.03M-32.662,000NVSTEnvista3.1817 of 5 stars$21.36+2.4%$20.21-5.4%-9.2%$3.68B$2.51B-3.2912,300Positive NewsPRCTPROCEPT BioRobotics3.0546 of 5 stars$65.15+4.7%$97.86+50.2%+23.5%$3.40B$199.84M-33.41430Earnings ReportLIVNLivaNova3.986 of 5 stars$49.50+4.3%$69.17+39.7%-24.5%$2.69B$1.15B117.862,900Analyst ForecastHigh Trading VolumeTMDXTransMedics Group2.8527 of 5 stars$77.12+7.2%$122.70+59.1%-16.2%$2.59B$241.62M82.04210Analyst RevisionENOVEnovis2.5653 of 5 stars$43.55+2.0%$58.75+34.9%-37.3%$2.48B$1.71B-19.886,550Earnings ReportAnalyst RevisionWRBYWarby Parker1.8861 of 5 stars$23.26-3.4%$21.92-5.7%+87.2%$2.36B$669.77M-86.133,491NVCRNovoCure3.6129 of 5 stars$21.24-3.8%$32.67+53.8%+13.3%$2.30B$509.34M-15.171,453Earnings ReportAnalyst DowngradeAnalyst RevisionLMATLeMaitre Vascular2.075 of 5 stars$102.03+2.5%$94.63-7.3%+36.4%$2.29B$213.03M55.75490Earnings ReportAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Inari Medical Competitors iRhythm Technologies Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors TransMedics Group Competitors Enovis Competitors Warby Parker Competitors NovoCure Competitors LeMaitre Vascular Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LQDA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
